Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles D Smith

Showing results (71-80 of 200) with videos related to

Pageof 20
Sort By:
Toxicology and Applied Pharmacology|September 10, 2013
Minocycline and doxycycline, but not other tetracycline-derived compounds, protect liver cells from chemical hypoxia and ischemia/reperfusion injury by inhibition of the mitochondrial calcium uniporterJustin Schwartz, Ekhson Holmuhamedov, Xun Zhang, et al.
Investigative Ophthalmology & Visual Science|October 27, 2006
Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseasesLynn W Maines, Kevin J French, Ellen B Wolpert, et al.
International Journal of Nephrology and Renovascular Disease|November 24, 2022
The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kidney Injury in MiceLynn W Maines, Cecelia L Green, Staci N Keller, et al.
Thyroid : Official Journal of the American Thyroid Association|November 11, 2014
Reversible cognitive, motor, and driving impairments in severe hypothyroidismCharles D Smith, Richard Grondin, William LeMaster, et al.
Cancers|May 11, 2024
Opaganib Downregulates N-Myc Expression and Suppresses In Vitro and In Vivo Growth of Neuroblastoma CellsLynn W Maines, Staci N Keller, Ryan A Smith, et al.
Annals of Neurology|May 24, 2006
Reply: GDNF poses troubling questions for doctors, drug makerJohn T Slevin, Greg A Gerhardt, Charles D Smith, et al.
Molecular Cancer Research : MCR|August 15, 2015
Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer ProgressionRandy S Schrecengost, Staci N Keller, Matthew J Schiewer, et al.
Neurology|August 9, 2017
Clinical Reasoning: Two see or not two see-Is it really double vision?Richard Ronan Murphy, Abdullah Al Sawaf, Danny R Rose, et al.
Neurobiology of Aging|September 24, 2008
Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairmentSarah B Martin, Charles D Smith, Heather R Collins, et al.
Molecular Cancer Therapeutics|September 3, 2011
Discovery and evaluation of inhibitors of human ceramidaseJeremiah M Draper, Zuping Xia, Ryan A Smith, et al.
Pageof 20

Showing results (71-80 of 200) with videos related to

Sort By:
Pageof 20
Toxicology and Applied Pharmacology|September 10, 2013
Minocycline and doxycycline, but not other tetracycline-derived compounds, protect liver cells from chemical hypoxia and ischemia/reperfusion injury by inhibition of the mitochondrial calcium uniporterJustin Schwartz, Ekhson Holmuhamedov, Xun Zhang, et al.
Investigative Ophthalmology & Visual Science|October 27, 2006
Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseasesLynn W Maines, Kevin J French, Ellen B Wolpert, et al.
International Journal of Nephrology and Renovascular Disease|November 24, 2022
The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kidney Injury in MiceLynn W Maines, Cecelia L Green, Staci N Keller, et al.
Thyroid : Official Journal of the American Thyroid Association|November 11, 2014
Reversible cognitive, motor, and driving impairments in severe hypothyroidismCharles D Smith, Richard Grondin, William LeMaster, et al.
Cancers|May 11, 2024
Opaganib Downregulates N-Myc Expression and Suppresses In Vitro and In Vivo Growth of Neuroblastoma CellsLynn W Maines, Staci N Keller, Ryan A Smith, et al.
Annals of Neurology|May 24, 2006
Reply: GDNF poses troubling questions for doctors, drug makerJohn T Slevin, Greg A Gerhardt, Charles D Smith, et al.
Molecular Cancer Research : MCR|August 15, 2015
Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer ProgressionRandy S Schrecengost, Staci N Keller, Matthew J Schiewer, et al.
Neurology|August 9, 2017
Clinical Reasoning: Two see or not two see-Is it really double vision?Richard Ronan Murphy, Abdullah Al Sawaf, Danny R Rose, et al.
Neurobiology of Aging|September 24, 2008
Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairmentSarah B Martin, Charles D Smith, Heather R Collins, et al.
Molecular Cancer Therapeutics|September 3, 2011
Discovery and evaluation of inhibitors of human ceramidaseJeremiah M Draper, Zuping Xia, Ryan A Smith, et al.
Pageof 20